The Procter & Gamble Company Website

The Procter & Gamble Company

NYSE-PG

Basic

  • Market Cap

    $385.17B

  • EV

    $411.4B

  • Shares Out

    2,360.14M

  • Revenue

    $84.06B

  • Employees

    107,000

Margins

  • Gross

    51.46%

  • EBITDA

    28.81%

  • Operating

    25.43%

  • Pre-Tax

    22.75%

  • Net

    17.99%

  • FCF

    19.22%

Returns (5Yr Avg)

  • ROA

    10.44%

  • ROTA

    53.57%

  • ROE

    26.46%

  • ROCE

    21.4%

  • ROIC

    13.46%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $170.26

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $6,828M

  • Net Debt

    $25.15B

  • Debt/Equity

    0.64

  • EBIT/Interest

    22.62

Growth (CAGR)

  • Rev 3Yr

    3.93%

  • Rev 5Yr

    4.61%

  • Rev 10Yr

    0.5%

  • Dil EPS 3Yr

    3.99%

  • Dil EPS 5Yr

    7.79%

  • Dil EPS 10Yr

    5.01%

  • Rev Fwd 2Yr

    3.16%

  • EBITDA Fwd 2Yr

    8.2%

  • EPS Fwd 2Yr

    8.49%

  • EPS LT Growth Est

    7.85%

Dividends

  • Yield

    —

  • Payout

    59.82%

  • DPS

    $3.76

  • DPS Growth 3Yr

    5.96%

  • DPS Growth 5Yr

    5.58%

  • DPS Growth 10Yr

    4.57%

  • DPS Growth Fwd 2Yr

    4.97%

Select a metric from the list below to chart it

Jun '14

Jun '15

Jun '16

Jun '17

Jun '18

Jun '19

Jun '20

Jun '21

Jun '22

Jun '23

LTM

Jun '24 (E)

Jun '25 (E)

Jun '26 (E)

Metric
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
LTM

Total Revenues

67,684

70,950

76,118

80,187

82,006

84,060

Total Revenues % Chg.

1.3%

4.8%

7.3%

5.3%

2.3%

3.8%

Cost of Goods Sold, Total

34,768

35,250

37,108

41,975

42,600

40,799

Gross Profit

32,916

35,700

39,010

38,212

39,406

43,261

Selling General & Admin Expenses, Total

18,709

19,597

20,527

19,518

20,349

21,884

Other Operating Expenses, Total

18,709

19,597

20,527

19,518

20,349

21,884

Operating Income

14,207

16,103

18,483

18,694

19,057

21,377

Interest Expense, Total

-509

-465

-502

-439

-756

-945

Interest And Investment Income

220

155

45

51

307

482

Net Interest Expenses

-289

-310

-457

-388

-449

-463

Other Non Operating Income (Expenses)

517

54

-392

-53

83

141

EBT, Excl. Unusual Items

14,435

15,847

17,634

18,253

18,691

21,055

Restructuring Charges

—

—

—

—

—

—

—

—

-253

-329

-581

Impairment of Goodwill

—

—

—

—

—

-6,800

—

—

—

—

—

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

—

Asset Writedown

—

—

—

—

—

-1,545

—

—

—

—

-1,341

Legal Settlements

—

—

—

—

—

—

—

—

—

—

Other Unusual Items

—

—

-21

-13

-19

-5

-9

-9

EBT, Incl. Unusual Items

6,069

15,834

17,615

17,995

18,353

19,124

Income Tax Expense

2,103

2,731

3,263

3,202

3,615

3,902

Earnings From Continuing Operations

3,966

13,103

14,352

14,793

14,738

15,222

Earnings Of Discontinued Operations

—

—

—

—

—

—

—

Minority Interest

-69

-76

-46

-51

-85

-96

Net Income

3,897

13,027

14,306

14,742

14,653

15,126

Preferred Dividend and Other Adjustments

263

263

271

281

282

281

Net Income to Common Incl Extra Items

3,634

12,764

14,035

14,461

14,371

14,845

Net Income to Common Excl. Extra Items

3,634

12,764

14,035

14,461

14,371

14,845

Total Shares Outstanding

2,504.8

2,479.7

2,429.7

2,393.9

2,362.1

2,360.1

Weighted Avg. Shares Outstanding

2,503.6

2,487.1

2,465.8

2,410.3

2,368.2

2,360.2

Weighted Avg. Shares Outstanding Dil

2,539.5

2,625.8

2,601

2,539.1

2,483.9

2,473.3

EPS

1.5

5.1

5.7

6

6.1

6.3

EPS Diluted

1.4

5

5.5

5.8

5.9

6.1

EBITDA

17,031

19,116

21,218

21,501

21,771

24,218

Effective Tax Rate

34.7%

17.2%

18.5%

17.8%

19.7%

20.4%